Scientific Reports · 2019 · 19 citations · 28 references
Life SciencesOncologyPharmacologyCell SignalingCellular MetabolismMolecular Cell BiologyCancer MetabolismImmune Cell MetabolismMetabolic ReprogrammingMetabolic Reprogramming In CancerMitochondrial SignalingTyrosine Kinase InhibitorsBioenergetic StressBruton Tyrosine KinaseBruton's Tyrosine Kinase InhibitorsBtk InhibitorsCellular Metabolic AdaptationMitochondrial Atp SynthesisSignalingTyrosine Kinase Inhibition
In this work we explored metabolic aspects of human primary leukemic lymphocytes that hold a potential impact on the treatment of Bruton tyrosine kinase (BTK)-driven diseases. Our results suggest that there is crosstalk between Bruton tyrosine kinase (BTK) signaling and bioenergetic stress responses. In primary chronic lymphocytic leukemia (CLL) lymphocytes, pharmacological interference with mitochondrial ATP synthesis or glucose metabolism affects BTK activity. Conversely, an inhibitor of BTK used clinically (ibrutinib) induces bioenergetic stress responses that in turn affect ibrutinib resistance. Although the detailed molecular mechanisms are still to be defined, our work shows for the first time that in primary B cells, metabolic stressors enhance BTK signaling and suggest that metabolic rewiring to hyperglycemia affects ibrutinib resistance in TP53 deficient chronic lymphocytic leukemia (CLL) lymphocytes.
28
Diabetes and Cancer: A Consensus Report
Edward L. Giovannucci, David M. Harlan, Michael C. Archer et al. · CA A Cancer Journal for Clinicians · 2010 · 1.1K citations · Full text
Medicine, Cancer Biology, Oncology +15
The regulation of AMP-activated protein kinase by phosphorylation
Silvie C. STEIN, Angela Woods, Neil A. Jones et al. · Biochemical Journal · 2000 · 599 citations · Full text